Medicine
Ravicti 1.1 g/mL oral liquid
Ravicti 1.1 g/mL oral liquid is a prescription medicine containing Glycerol phenylbutyrate for oral use, marketed by Horizon Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°-25°C (68°-77°F) with excursions permitted to 15°-30°C (59°-86°F).
Key facts
- Active ingredient (INN)
- Glycerol phenylbutyrate
- Brand
- Ravicti
- Strength
- 1.1 g/mL
- Dosage form
- Oral liquid
- Route
- Oral
- Packs
- 1 bottle, 4 bottles
- Marketing authorisation holder
- Horizon Therapeutics
- Manufacturer
- Horizon Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store at 20°-25°C (68°-77°F) with excursions permitted to 15°-30°C (59°-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A16AX09 Glycerol phenylbutyrate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 February 2013
- Identifiers
- RxCUI 1368453, 1368459DailyMed set ID 900e7dc0-9afe-4f50-80de-90567bb78519NDC 75987-050Application NDA203284
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 25 mL in 1 bottle | 75987-050-06 | Horizon Therapeutics | 28 February 2013 |
| 4 bottle in 1 carton / 25 mL in 1 bottle | 75987-050-07 | Horizon Therapeutics | 28 February 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Glycerol phenylbutyrate 1.1 g/mL oral liquid.
Clinical summary
Glycerol phenylbutyrate is a nitrogen binding agent indicated as a nitrogen-binding agent for chronic management of patients with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. MedsAcross supplies Glycerol phenylbutyrate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Glycerol phenylbutyrateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ravicti prescribing information (Horizon Therapeutics) · U.S. National Library of Medicine, DailyMed
- Ravicti: European public assessment report (EPAR) · European Medicines Agency
Need Ravicti 1.1 g/mL oral liquid for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.